Exact Sciences (EXAS), you all should have taken profits on Exact around $60 when I told you to reduce to a normal weight position, is under big pressure today from this study:

Liquid Biopsy Shows Promise for Colon Cancer

Seeking Alpha put out a note as well:

Exact Sciences under pressure on potential CRC blood screening test; shares down 9%

Richard Marzouka, one of the few dozen people I follow on SA (see my profile to find good people to follow), and I just found out a subscriber, gave me a heads up this morning. Here's my reply in note I sent back to him:To read more, a subscription is needed: Click here to subscribe